Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
3.
Head Neck ; 38(7): E2457-E2460, 2016 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-27028528

RESUMO

BACKGROUND: Esthesioneuroblastoma (ENB) is a rare, poorly characterized, intranasal cancer arising from olfactory neuroepithelium. METHODS: This case report reviews the underlying pathophysiology, clinical presentation, and diagnosis of primary ENB and parotid metastases. RESULTS: We present the case of a 43-year-old man who was referred to our practice with radiographically and biopsy confirmed ENB. After neoadjuvant chemotherapy, radiation, and open surgical resection, he returned to the clinic 30 months postoperatively with a right parotid mass, which was found to be a recurrence of his primary cancer. A parotidectomy was performed; however, he returned 10 months later with a new left parotid mass. Subsequent imaging and biopsy confirmed recurrence of ENB and a second parotidectomy was performed. CONCLUSION: This case illustrates that delayed metastases in the setting of ENB are not limited to the cervical lymph nodes and, in rare instances, may involve the parotid glands. Surveillance should include the parotid lymph node basin with a high clinical index of suspicion in the setting of parotid lymphadenopathy after primary surgical therapy. © 2016 Wiley Periodicals, Inc. Head Neck 38: E2457-E2460, 2016.

4.
J Clin Microbiol ; 49(4): 1518-23, 2011 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21270229

RESUMO

"Pseudomonas andersonii" is a Gram-negative bacillus initially isolated from a granulomatous lung lesion. Novel species status has not been validated for this single strain. We report four additional cases of pulmonary granuloma involving P. andersonii and further characterize the organism. These patients had pulmonary nodules that were surgically resected and which grew P. andersonii on routine culture. Mycobacterium avium complex was concomitantly isolated in two cases, and fungal structures were identified histopathologically in two other cases. The five P. andersonii strains described to date were similar in growth characteristics, biochemical reactions, matrix-assisted laser desorption ionization-time of flight mass spectrometry protein profiles, and susceptibility to antimicrobial agents. Their 16S rRNA genes were 99.9 to 100% identical but less than 95.0% similar to those of all other known bacteria. The gyrA genes of these strains were 99.5 to 100% identical. These shared features illustrate P. andersonii as a unique and distinct bacterium and support the novel species status of the organism.


Assuntos
Granuloma do Sistema Respiratório/microbiologia , Infecções por Pseudomonas/microbiologia , Pseudomonas/isolamento & purificação , Idoso , Proteínas de Bactérias/análise , Técnicas de Tipagem Bacteriana , DNA Bacteriano/química , DNA Bacteriano/genética , DNA Ribossômico/química , DNA Ribossômico/genética , Feminino , Granuloma do Sistema Respiratório/patologia , Humanos , Pulmão/microbiologia , Pulmão/patologia , Masculino , Testes de Sensibilidade Microbiana , Pessoa de Meia-Idade , Dados de Sequência Molecular , Complexo Mycobacterium avium/isolamento & purificação , Pseudomonas/química , Pseudomonas/genética , Pseudomonas/metabolismo , Infecções por Pseudomonas/patologia , RNA Ribossômico 16S/genética , Análise de Sequência de DNA , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz
5.
J Hum Virol ; 4(6): 306-16, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-12082397

RESUMO

OBJECTIVES: Immunity to the human immunodeficiency virus type-1 (HIV-1) G/P-92 fusion protein consisting of highly immunogenic regions of Gag (p17 and p24) and Pol (p51) expressed in recombinant vaccinia virus (vG/P-92) was compared with responses to the entire viral Gag-Pol precursor protein (vVK1). STUDY DESIGN/METHODS: We analyzed the level of Gag and Pol protein expression in vG/P-92-infected cells as well as the ability of the G/P-92 fusion protein to form virus-like particles (VLP) in infected cultures. The efficacy of vG/P-92 and vVK1 vaccines was evaluated in a murine model by measuring T helper (Th), cytotoxic T lymphocyte (CTL), and antibody responses to Gag and Pol antigens. RESULTS: The deletion of a frameshift site resulted in an increased level of Pol in cells expressing the G/P-92 fusion protein. Particles budding from the plasma membrane were detected in both vG/P-92- and vVK1-infected cells, but the release of VLP was less efficient from cells expressing the G/P-92 fusion protein than the entire gag-pol gene product. Immunization with vG/P-92 vector elicited a higher level of cellular and humoral responses to both Gag and Pol antigens than the vVK1 vaccine. CONCLUSIONS: The enhanced immunogenicity of the G/P-92 fusion protein compared with the entire viral gag-pol gene product might be related to a higher intracellular level of Pol and Gag expression due to the deletion of a frameshift site and less efficient transport of VLP from vG/P-92-infected cells, respectively.


Assuntos
Vacinas contra a AIDS/imunologia , Produtos do Gene gag/imunologia , Antígenos HIV/imunologia , Proteína do Núcleo p24 do HIV/imunologia , Transcriptase Reversa do HIV/imunologia , HIV-1/imunologia , Vacinas Sintéticas/imunologia , Proteínas Virais , Vacinas contra a AIDS/biossíntese , Vacinas contra a AIDS/genética , Animais , Formação de Anticorpos/imunologia , Expressão Gênica , Produtos do Gene gag/biossíntese , Produtos do Gene gag/genética , Vetores Genéticos , Antígenos H-2/genética , Anticorpos Anti-HIV/sangue , Anticorpos Anti-HIV/imunologia , Antígenos HIV/biossíntese , Antígenos HIV/genética , Proteína do Núcleo p24 do HIV/biossíntese , Proteína do Núcleo p24 do HIV/genética , Transcriptase Reversa do HIV/biossíntese , Transcriptase Reversa do HIV/genética , HIV-1/genética , Antígeno HLA-A2/genética , Células HeLa , Humanos , Imunidade Celular/imunologia , Células Jurkat , Camundongos , Camundongos Transgênicos , Proteínas Recombinantes de Fusão/biossíntese , Proteínas Recombinantes de Fusão/genética , Proteínas Recombinantes de Fusão/imunologia , Vacinação , Vacinas Sintéticas/biossíntese , Vacinas Sintéticas/genética , Vaccinia virus , Vírion , Produtos do Gene gag do Vírus da Imunodeficiência Humana
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA